nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—atopic dermatitis—psoriasis	0.156	1	CtDrD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Fluocinolone Acetonide—psoriasis	0.0692	0.25	CiPCiCtD
Fluocinonide—Clobetasol propionate—psoriasis	0.0594	0.273	CrCtD
Fluocinonide—Beclomethasone—psoriasis	0.0476	0.218	CrCtD
Fluocinonide—Fluocinolone Acetonide—psoriasis	0.0463	0.212	CrCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Hydrocortisone—psoriasis	0.0398	0.144	CiPCiCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Dexamethasone—psoriasis	0.035	0.127	CiPCiCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Betamethasone—psoriasis	0.035	0.127	CiPCiCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Triamcinolone—psoriasis	0.0338	0.122	CiPCiCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Prednisolone—psoriasis	0.0328	0.118	CiPCiCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Prednisone—psoriasis	0.0309	0.112	CiPCiCtD
Fluocinonide—SERPINA6—Fluocinolone Acetonide—psoriasis	0.0277	0.193	CbGbCtD
Fluocinonide—SERPINA6—Beclomethasone—psoriasis	0.0277	0.193	CbGbCtD
Fluocinonide—Dexamethasone—psoriasis	0.0217	0.0996	CrCtD
Fluocinonide—Betamethasone—psoriasis	0.0217	0.0996	CrCtD
Fluocinonide—Triamcinolone—psoriasis	0.0212	0.0973	CrCtD
Fluocinonide—NR3C1—Clobetasol propionate—psoriasis	0.0171	0.119	CbGbCtD
Fluocinonide—NR3C1—Fluocinolone Acetonide—psoriasis	0.0129	0.0902	CbGbCtD
Fluocinonide—NR3C1—Beclomethasone—psoriasis	0.0129	0.0902	CbGbCtD
Fluocinonide—SERPINA6—Triamcinolone—psoriasis	0.011	0.0769	CbGbCtD
Fluocinonide—SERPINA6—Prednisolone—psoriasis	0.00933	0.0651	CbGbCtD
Fluocinonide—NR3C1—Triamcinolone—psoriasis	0.00515	0.0359	CbGbCtD
Fluocinonide—NR3C1—Betamethasone—psoriasis	0.00442	0.0308	CbGbCtD
Fluocinonide—NR3C1—Prednisolone—psoriasis	0.00436	0.0304	CbGbCtD
Fluocinonide—NR3C1—Hydrocortisone—psoriasis	0.00413	0.0288	CbGbCtD
Fluocinonide—NR3C1—Prednisone—psoriasis	0.00412	0.0287	CbGbCtD
Fluocinonide—NR3C1—Dexamethasone—psoriasis	0.00257	0.0179	CbGbCtD
Fluocinonide—Ciclesonide—Clobetasol propionate—psoriasis	0.00206	0.013	CrCrCtD
Fluocinonide—Fluticasone furoate—Clobetasol propionate—psoriasis	0.00198	0.0125	CrCrCtD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—KRT10—psoriasis	0.00181	0.346	CbGpPWpGaD
Fluocinonide—Flumethasone Pivalate—Clobetasol propionate—psoriasis	0.00178	0.0112	CrCrCtD
Fluocinonide—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.00172	0.0108	CrCrCtD
Fluocinonide—Difluprednate—Clobetasol propionate—psoriasis	0.00172	0.0108	CrCrCtD
Fluocinonide—Halobetasol Propionate—Clobetasol propionate—psoriasis	0.00172	0.0108	CrCrCtD
Fluocinonide—Ciclesonide—Beclomethasone—psoriasis	0.00165	0.0104	CrCrCtD
Fluocinonide—Clocortolone—Clobetasol propionate—psoriasis	0.00162	0.0102	CrCrCtD
Fluocinonide—Beclomethasone—Clobetasol propionate—psoriasis	0.00162	0.0102	CrCrCtD
Fluocinonide—Fluticasone furoate—Beclomethasone—psoriasis	0.00159	0.00999	CrCrCtD
Fluocinonide—Fluticasone furoate—Fluocinolone Acetonide—psoriasis	0.00154	0.00971	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Clobetasol propionate—psoriasis	0.00153	0.00963	CrCrCtD
Fluocinonide—Amcinonide—Clobetasol propionate—psoriasis	0.00149	0.00938	CrCrCtD
Fluocinonide—Budesonide—Clobetasol propionate—psoriasis	0.00149	0.00938	CrCrCtD
Fluocinonide—Desonide—Clobetasol propionate—psoriasis	0.00145	0.00913	CrCrCtD
Fluocinonide—Diflorasone—Clobetasol propionate—psoriasis	0.00145	0.00913	CrCrCtD
Fluocinonide—Flurandrenolide—Fluocinolone Acetonide—psoriasis	0.00143	0.00903	CrCrCtD
Fluocinonide—Flumethasone Pivalate—Beclomethasone—psoriasis	0.00143	0.00898	CrCrCtD
Fluocinonide—Paramethasone—Clobetasol propionate—psoriasis	0.00142	0.0089	CrCrCtD
Fluocinonide—Flumethasone Pivalate—Fluocinolone Acetonide—psoriasis	0.00139	0.00872	CrCrCtD
Fluocinonide—Halobetasol Propionate—Beclomethasone—psoriasis	0.00138	0.00869	CrCrCtD
Fluocinonide—Difluprednate—Beclomethasone—psoriasis	0.00138	0.00869	CrCrCtD
Fluocinonide—Fluticasone Propionate—Beclomethasone—psoriasis	0.00138	0.00869	CrCrCtD
Fluocinonide—Desoximetasone—Clobetasol propionate—psoriasis	0.00138	0.00869	CrCrCtD
Fluocinonide—Fluorometholone—Clobetasol propionate—psoriasis	0.00135	0.00848	CrCrCtD
Fluocinonide—Triamcinolone—Clobetasol propionate—psoriasis	0.00135	0.00848	CrCrCtD
Fluocinonide—Mometasone—Clobetasol propionate—psoriasis	0.00135	0.00848	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Clobetasol propionate—psoriasis	0.00135	0.00848	CrCrCtD
Fluocinonide—Halobetasol Propionate—Fluocinolone Acetonide—psoriasis	0.00134	0.00844	CrCrCtD
Fluocinonide—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.00134	0.00844	CrCrCtD
Fluocinonide—Difluprednate—Fluocinolone Acetonide—psoriasis	0.00134	0.00844	CrCrCtD
Fluocinonide—Betamethasone—Clobetasol propionate—psoriasis	0.00132	0.00829	CrCrCtD
Fluocinonide—Dexamethasone—Clobetasol propionate—psoriasis	0.00132	0.00829	CrCrCtD
Fluocinonide—Rimexolone—Clobetasol propionate—psoriasis	0.00132	0.00829	CrCrCtD
Fluocinonide—Clocortolone—Beclomethasone—psoriasis	0.0013	0.00817	CrCrCtD
Fluocinonide—Beclomethasone—Fluocinolone Acetonide—psoriasis	0.00126	0.00794	CrCrCtD
Fluocinonide—Clocortolone—Fluocinolone Acetonide—psoriasis	0.00126	0.00794	CrCrCtD
Fluocinonide—Methylprednisolone—Clobetasol propionate—psoriasis	0.00126	0.00793	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Beclomethasone—psoriasis	0.00123	0.00772	CrCrCtD
Fluocinonide—Fluocortolone—Fluocinolone Acetonide—psoriasis	0.00123	0.00771	CrCrCtD
Fluocinonide—Budesonide—Beclomethasone—psoriasis	0.00119	0.00751	CrCrCtD
Fluocinonide—Amcinonide—Beclomethasone—psoriasis	0.00119	0.00751	CrCrCtD
Fluocinonide—Clobetasol propionate—Beclomethasone—psoriasis	0.00116	0.00732	CrCrCtD
Fluocinonide—Desonide—Beclomethasone—psoriasis	0.00116	0.00732	CrCrCtD
Fluocinonide—Diflorasone—Beclomethasone—psoriasis	0.00116	0.00732	CrCrCtD
Fluocinonide—Budesonide—Fluocinolone Acetonide—psoriasis	0.00116	0.0073	CrCrCtD
Fluocinonide—Amcinonide—Fluocinolone Acetonide—psoriasis	0.00116	0.0073	CrCrCtD
Fluocinonide—Flunisolide—Fluocinolone Acetonide—psoriasis	0.00113	0.00711	CrCrCtD
Fluocinonide—Diflorasone—Fluocinolone Acetonide—psoriasis	0.00113	0.00711	CrCrCtD
Fluocinonide—Desonide—Fluocinolone Acetonide—psoriasis	0.00113	0.00711	CrCrCtD
Fluocinonide—Clobetasol propionate—Fluocinolone Acetonide—psoriasis	0.00113	0.00711	CrCrCtD
Fluocinonide—Desoximetasone—Beclomethasone—psoriasis	0.00111	0.00696	CrCrCtD
Fluocinonide—Paramethasone—Fluocinolone Acetonide—psoriasis	0.0011	0.00693	CrCrCtD
Fluocinonide—Fluorometholone—Beclomethasone—psoriasis	0.00108	0.00679	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Beclomethasone—psoriasis	0.00108	0.00679	CrCrCtD
Fluocinonide—Triamcinolone—Beclomethasone—psoriasis	0.00108	0.00679	CrCrCtD
Fluocinonide—Mometasone—Beclomethasone—psoriasis	0.00108	0.00679	CrCrCtD
Fluocinonide—Desoximetasone—Fluocinolone Acetonide—psoriasis	0.00108	0.00676	CrCrCtD
Fluocinonide—Rimexolone—Beclomethasone—psoriasis	0.00106	0.00664	CrCrCtD
Fluocinonide—Dexamethasone—Beclomethasone—psoriasis	0.00106	0.00664	CrCrCtD
Fluocinonide—Betamethasone—Beclomethasone—psoriasis	0.00106	0.00664	CrCrCtD
Fluocinonide—Triamcinolone—Fluocinolone Acetonide—psoriasis	0.00105	0.0066	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Fluocinolone Acetonide—psoriasis	0.00105	0.0066	CrCrCtD
Fluocinonide—Mometasone—Fluocinolone Acetonide—psoriasis	0.00105	0.0066	CrCrCtD
Fluocinonide—Fluorometholone—Fluocinolone Acetonide—psoriasis	0.00105	0.0066	CrCrCtD
Fluocinonide—Betamethasone—Fluocinolone Acetonide—psoriasis	0.00103	0.00645	CrCrCtD
Fluocinonide—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.00103	0.00645	CrCrCtD
Fluocinonide—Rimexolone—Fluocinolone Acetonide—psoriasis	0.00103	0.00645	CrCrCtD
Fluocinonide—Methylprednisolone—Fluocinolone Acetonide—psoriasis	0.000981	0.00617	CrCrCtD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—IVL—psoriasis	0.000884	0.169	CbGpPWpGaD
Fluocinonide—Ciclesonide—Hydrocortisone—psoriasis	0.00081	0.0051	CrCrCtD
Fluocinonide—Flurandrenolide—Hydrocortisone—psoriasis	0.000725	0.00456	CrCrCtD
Fluocinonide—Fluticasone furoate—Betamethasone—psoriasis	0.000724	0.00455	CrCrCtD
Fluocinonide—Fluticasone furoate—Dexamethasone—psoriasis	0.000724	0.00455	CrCrCtD
Fluocinonide—Fluticasone furoate—Triamcinolone—psoriasis	0.000707	0.00445	CrCrCtD
Fluocinonide—Ciclesonide—Prednisone—psoriasis	0.000698	0.00439	CrCrCtD
Fluocinonide—Ciclesonide—Prednisolone—psoriasis	0.000681	0.00429	CrCrCtD
Fluocinonide—Flurandrenolide—Dexamethasone—psoriasis	0.000673	0.00423	CrCrCtD
Fluocinonide—Flurandrenolide—Betamethasone—psoriasis	0.000673	0.00423	CrCrCtD
Fluocinonide—Flumethasone Pivalate—Betamethasone—psoriasis	0.00065	0.00409	CrCrCtD
Fluocinonide—Flumethasone Pivalate—Dexamethasone—psoriasis	0.00065	0.00409	CrCrCtD
Fluocinonide—Flumethasone Pivalate—Triamcinolone—psoriasis	0.000636	0.004	CrCrCtD
Fluocinonide—Halobetasol Propionate—Dexamethasone—psoriasis	0.00063	0.00396	CrCrCtD
Fluocinonide—Halobetasol Propionate—Betamethasone—psoriasis	0.00063	0.00396	CrCrCtD
Fluocinonide—Fluticasone Propionate—Dexamethasone—psoriasis	0.00063	0.00396	CrCrCtD
Fluocinonide—Fluticasone Propionate—Betamethasone—psoriasis	0.00063	0.00396	CrCrCtD
Fluocinonide—Difluprednate—Betamethasone—psoriasis	0.00063	0.00396	CrCrCtD
Fluocinonide—Difluprednate—Dexamethasone—psoriasis	0.00063	0.00396	CrCrCtD
Fluocinonide—Fluticasone Propionate—Triamcinolone—psoriasis	0.000615	0.00387	CrCrCtD
Fluocinonide—Halobetasol Propionate—Triamcinolone—psoriasis	0.000615	0.00387	CrCrCtD
Fluocinonide—Difluprednate—Triamcinolone—psoriasis	0.000615	0.00387	CrCrCtD
Fluocinonide—Flurandrenolide—Prednisolone—psoriasis	0.000609	0.00383	CrCrCtD
Fluocinonide—Beclomethasone—Betamethasone—psoriasis	0.000592	0.00372	CrCrCtD
Fluocinonide—Clocortolone—Betamethasone—psoriasis	0.000592	0.00372	CrCrCtD
Fluocinonide—Clocortolone—Dexamethasone—psoriasis	0.000592	0.00372	CrCrCtD
Fluocinonide—Beclomethasone—Dexamethasone—psoriasis	0.000592	0.00372	CrCrCtD
Fluocinonide—Budesonide—Hydrocortisone—psoriasis	0.000586	0.00369	CrCrCtD
Fluocinonide—Clocortolone—Triamcinolone—psoriasis	0.000578	0.00364	CrCrCtD
Fluocinonide—Beclomethasone—Triamcinolone—psoriasis	0.000578	0.00364	CrCrCtD
Fluocinonide—Fluocortolone—Betamethasone—psoriasis	0.000575	0.00362	CrCrCtD
Fluocinonide—Fluocortolone—Dexamethasone—psoriasis	0.000575	0.00362	CrCrCtD
Fluocinonide—Desonide—Hydrocortisone—psoriasis	0.000571	0.00359	CrCrCtD
Fluocinonide—Flunisolide—Hydrocortisone—psoriasis	0.000571	0.00359	CrCrCtD
Fluocinonide—Fluocortolone—Triamcinolone—psoriasis	0.000562	0.00353	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Dexamethasone—psoriasis	0.000559	0.00352	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Betamethasone—psoriasis	0.000559	0.00352	CrCrCtD
Fluocinonide—Paramethasone—Hydrocortisone—psoriasis	0.000556	0.0035	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Triamcinolone—psoriasis	0.000546	0.00344	CrCrCtD
Fluocinonide—Amcinonide—Betamethasone—psoriasis	0.000544	0.00342	CrCrCtD
Fluocinonide—Budesonide—Dexamethasone—psoriasis	0.000544	0.00342	CrCrCtD
Fluocinonide—Amcinonide—Dexamethasone—psoriasis	0.000544	0.00342	CrCrCtD
Fluocinonide—Budesonide—Betamethasone—psoriasis	0.000544	0.00342	CrCrCtD
Fluocinonide—Desoximetasone—Hydrocortisone—psoriasis	0.000543	0.00342	CrCrCtD
Fluocinonide—Beclomethasone—Prednisolone—psoriasis	0.000536	0.00337	CrCrCtD
Fluocinonide—Clocortolone—Prednisolone—psoriasis	0.000536	0.00337	CrCrCtD
Fluocinonide—Fluocortolone—Prednisone—psoriasis	0.000533	0.00335	CrCrCtD
Fluocinonide—Budesonide—Triamcinolone—psoriasis	0.000532	0.00334	CrCrCtD
Fluocinonide—Amcinonide—Triamcinolone—psoriasis	0.000532	0.00334	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Hydrocortisone—psoriasis	0.00053	0.00333	CrCrCtD
Fluocinonide—Mometasone—Hydrocortisone—psoriasis	0.00053	0.00333	CrCrCtD
Fluocinonide—Triamcinolone—Hydrocortisone—psoriasis	0.00053	0.00333	CrCrCtD
Fluocinonide—Fluorometholone—Hydrocortisone—psoriasis	0.00053	0.00333	CrCrCtD
Fluocinonide—Desonide—Dexamethasone—psoriasis	0.00053	0.00333	CrCrCtD
Fluocinonide—Clobetasol propionate—Betamethasone—psoriasis	0.00053	0.00333	CrCrCtD
Fluocinonide—Clobetasol propionate—Dexamethasone—psoriasis	0.00053	0.00333	CrCrCtD
Fluocinonide—Diflorasone—Dexamethasone—psoriasis	0.00053	0.00333	CrCrCtD
Fluocinonide—Flunisolide—Betamethasone—psoriasis	0.00053	0.00333	CrCrCtD
Fluocinonide—Flunisolide—Dexamethasone—psoriasis	0.00053	0.00333	CrCrCtD
Fluocinonide—Diflorasone—Betamethasone—psoriasis	0.00053	0.00333	CrCrCtD
Fluocinonide—Desonide—Betamethasone—psoriasis	0.00053	0.00333	CrCrCtD
Fluocinonide—Fluocortolone—Prednisolone—psoriasis	0.00052	0.00327	CrCrCtD
Fluocinonide—Dexamethasone—Hydrocortisone—psoriasis	0.000518	0.00326	CrCrCtD
Fluocinonide—Rimexolone—Hydrocortisone—psoriasis	0.000518	0.00326	CrCrCtD
Fluocinonide—Betamethasone—Hydrocortisone—psoriasis	0.000518	0.00326	CrCrCtD
Fluocinonide—Desonide—Triamcinolone—psoriasis	0.000518	0.00326	CrCrCtD
Fluocinonide—Diflorasone—Triamcinolone—psoriasis	0.000518	0.00326	CrCrCtD
Fluocinonide—Flunisolide—Triamcinolone—psoriasis	0.000518	0.00326	CrCrCtD
Fluocinonide—Clobetasol propionate—Triamcinolone—psoriasis	0.000518	0.00326	CrCrCtD
Fluocinonide—Paramethasone—Dexamethasone—psoriasis	0.000517	0.00325	CrCrCtD
Fluocinonide—Paramethasone—Betamethasone—psoriasis	0.000517	0.00325	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Prednisolone—psoriasis	0.000506	0.00318	CrCrCtD
Fluocinonide—Paramethasone—Triamcinolone—psoriasis	0.000505	0.00318	CrCrCtD
Fluocinonide—Budesonide—Prednisone—psoriasis	0.000505	0.00317	CrCrCtD
Fluocinonide—Amcinonide—Prednisone—psoriasis	0.000505	0.00317	CrCrCtD
Fluocinonide—Desoximetasone—Betamethasone—psoriasis	0.000504	0.00317	CrCrCtD
Fluocinonide—Desoximetasone—Dexamethasone—psoriasis	0.000504	0.00317	CrCrCtD
Fluocinonide—Methylprednisolone—Hydrocortisone—psoriasis	0.000495	0.00312	CrCrCtD
Fluocinonide—Desoximetasone—Triamcinolone—psoriasis	0.000493	0.0031	CrCrCtD
Fluocinonide—Budesonide—Prednisolone—psoriasis	0.000493	0.0031	CrCrCtD
Fluocinonide—Amcinonide—Prednisolone—psoriasis	0.000493	0.0031	CrCrCtD
Fluocinonide—Mometasone—Dexamethasone—psoriasis	0.000492	0.0031	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Dexamethasone—psoriasis	0.000492	0.0031	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Betamethasone—psoriasis	0.000492	0.0031	CrCrCtD
Fluocinonide—Fluorometholone—Dexamethasone—psoriasis	0.000492	0.0031	CrCrCtD
Fluocinonide—Triamcinolone—Betamethasone—psoriasis	0.000492	0.0031	CrCrCtD
Fluocinonide—Fluorometholone—Betamethasone—psoriasis	0.000492	0.0031	CrCrCtD
Fluocinonide—Triamcinolone—Dexamethasone—psoriasis	0.000492	0.0031	CrCrCtD
Fluocinonide—Mometasone—Betamethasone—psoriasis	0.000492	0.0031	CrCrCtD
Fluocinonide—Clobetasol propionate—Prednisone—psoriasis	0.000492	0.00309	CrCrCtD
Fluocinonide—Desonide—Prednisone—psoriasis	0.000492	0.00309	CrCrCtD
Fluocinonide—Flunisolide—Prednisone—psoriasis	0.000492	0.00309	CrCrCtD
Fluocinonide—Diflorasone—Prednisone—psoriasis	0.000492	0.00309	CrCrCtD
Fluocinonide—Betamethasone—Dexamethasone—psoriasis	0.000481	0.00303	CrCrCtD
Fluocinonide—Rimexolone—Betamethasone—psoriasis	0.000481	0.00303	CrCrCtD
Fluocinonide—Rimexolone—Dexamethasone—psoriasis	0.000481	0.00303	CrCrCtD
Fluocinonide—Dexamethasone—Betamethasone—psoriasis	0.000481	0.00303	CrCrCtD
Fluocinonide—Mometasone—Triamcinolone—psoriasis	0.000481	0.00303	CrCrCtD
Fluocinonide—Fluorometholone—Triamcinolone—psoriasis	0.000481	0.00303	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Triamcinolone—psoriasis	0.000481	0.00303	CrCrCtD
Fluocinonide—Clobetasol propionate—Prednisolone—psoriasis	0.00048	0.00302	CrCrCtD
Fluocinonide—Desonide—Prednisolone—psoriasis	0.00048	0.00302	CrCrCtD
Fluocinonide—Diflorasone—Prednisolone—psoriasis	0.00048	0.00302	CrCrCtD
Fluocinonide—Flunisolide—Prednisolone—psoriasis	0.00048	0.00302	CrCrCtD
Fluocinonide—Paramethasone—Prednisone—psoriasis	0.000479	0.00301	CrCrCtD
Fluocinonide—Betamethasone—Triamcinolone—psoriasis	0.00047	0.00296	CrCrCtD
Fluocinonide—Rimexolone—Triamcinolone—psoriasis	0.00047	0.00296	CrCrCtD
Fluocinonide—Dexamethasone—Triamcinolone—psoriasis	0.00047	0.00296	CrCrCtD
Fluocinonide—Paramethasone—Prednisolone—psoriasis	0.000468	0.00294	CrCrCtD
Fluocinonide—Desoximetasone—Prednisone—psoriasis	0.000468	0.00294	CrCrCtD
Fluocinonide—Methylprednisolone—Betamethasone—psoriasis	0.00046	0.00289	CrCrCtD
Fluocinonide—Methylprednisolone—Dexamethasone—psoriasis	0.00046	0.00289	CrCrCtD
Fluocinonide—Triamcinolone—Prednisone—psoriasis	0.000456	0.00287	CrCrCtD
Fluocinonide—Mometasone—Prednisone—psoriasis	0.000456	0.00287	CrCrCtD
Fluocinonide—Fluorometholone—Prednisone—psoriasis	0.000456	0.00287	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Prednisone—psoriasis	0.000456	0.00287	CrCrCtD
Fluocinonide—Desoximetasone—Prednisolone—psoriasis	0.000456	0.00287	CrCrCtD
Fluocinonide—Methylprednisolone—Triamcinolone—psoriasis	0.00045	0.00283	CrCrCtD
Fluocinonide—Betamethasone—Prednisone—psoriasis	0.000446	0.00281	CrCrCtD
Fluocinonide—Rimexolone—Prednisone—psoriasis	0.000446	0.00281	CrCrCtD
Fluocinonide—Dexamethasone—Prednisone—psoriasis	0.000446	0.00281	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Prednisolone—psoriasis	0.000446	0.0028	CrCrCtD
Fluocinonide—Mometasone—Prednisolone—psoriasis	0.000446	0.0028	CrCrCtD
Fluocinonide—Triamcinolone—Prednisolone—psoriasis	0.000446	0.0028	CrCrCtD
Fluocinonide—Fluorometholone—Prednisolone—psoriasis	0.000446	0.0028	CrCrCtD
Fluocinonide—Dexamethasone—Prednisolone—psoriasis	0.000435	0.00274	CrCrCtD
Fluocinonide—Betamethasone—Prednisolone—psoriasis	0.000435	0.00274	CrCrCtD
Fluocinonide—Rimexolone—Prednisolone—psoriasis	0.000435	0.00274	CrCrCtD
Fluocinonide—Methylprednisolone—Prednisone—psoriasis	0.000427	0.00268	CrCrCtD
Fluocinonide—Methylprednisolone—Prednisolone—psoriasis	0.000416	0.00262	CrCrCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000142	0.0272	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—HCAR2—psoriasis	0.000127	0.0243	CbGpPWpGaD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—NFKB1—psoriasis	0.000104	0.02	CbGpPWpGaD
Fluocinonide—Glycosuria—Acitretin—psoriasis	0.000103	0.00248	CcSEcCtD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CARM1—psoriasis	0.000103	0.0196	CbGpPWpGaD
Fluocinonide—Skin exfoliation—Methoxsalen—psoriasis	0.000101	0.00242	CcSEcCtD
Fluocinonide—Dermatitis acneiform—Betamethasone—psoriasis	9.91e-05	0.00238	CcSEcCtD
Fluocinonide—Dermatitis acneiform—Dexamethasone—psoriasis	9.91e-05	0.00238	CcSEcCtD
Fluocinonide—Dry skin—Clobetasol propionate—psoriasis	9.88e-05	0.00237	CcSEcCtD
Fluocinonide—Hypertrichosis—Triamcinolone—psoriasis	9.81e-05	0.00236	CcSEcCtD
Fluocinonide—Skin atrophy—Prednisone—psoriasis	9.76e-05	0.00234	CcSEcCtD
Fluocinonide—Allergic contact dermatitis—Dexamethasone—psoriasis	9.69e-05	0.00233	CcSEcCtD
Fluocinonide—Allergic contact dermatitis—Betamethasone—psoriasis	9.69e-05	0.00233	CcSEcCtD
Fluocinonide—Leukoderma—Prednisolone—psoriasis	9.54e-05	0.00229	CcSEcCtD
Fluocinonide—Leukoderma—Hydrocortisone—psoriasis	9.32e-05	0.00224	CcSEcCtD
Fluocinonide—Skin striae—Prednisone—psoriasis	9.27e-05	0.00223	CcSEcCtD
Fluocinonide—Atrophy—Prednisone—psoriasis	9.05e-05	0.00217	CcSEcCtD
Fluocinonide—Application site pain—Hydrocortisone—psoriasis	9.01e-05	0.00216	CcSEcCtD
Fluocinonide—Hypertrichosis—Dexamethasone—psoriasis	8.91e-05	0.00214	CcSEcCtD
Fluocinonide—Hypertrichosis—Betamethasone—psoriasis	8.91e-05	0.00214	CcSEcCtD
Fluocinonide—Leukoderma—Triamcinolone—psoriasis	8.78e-05	0.00211	CcSEcCtD
Fluocinonide—Nasopharyngitis—Beclomethasone—psoriasis	8.77e-05	0.00211	CcSEcCtD
Fluocinonide—Dermatitis acneiform—Prednisone—psoriasis	8.63e-05	0.00207	CcSEcCtD
Fluocinonide—Application site reaction—Hydrocortisone—psoriasis	8.45e-05	0.00203	CcSEcCtD
Fluocinonide—Hyperglycaemia—Clobetasol propionate—psoriasis	8.4e-05	0.00202	CcSEcCtD
Fluocinonide—Dermatitis contact—Fluocinolone Acetonide—psoriasis	8.26e-05	0.00198	CcSEcCtD
Fluocinonide—Skin exfoliation—Acitretin—psoriasis	8e-05	0.00192	CcSEcCtD
Fluocinonide—Leukoderma—Betamethasone—psoriasis	7.96e-05	0.00191	CcSEcCtD
Fluocinonide—Leukoderma—Dexamethasone—psoriasis	7.96e-05	0.00191	CcSEcCtD
Fluocinonide—Application site reaction—Triamcinolone—psoriasis	7.96e-05	0.00191	CcSEcCtD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—REL—psoriasis	7.82e-05	0.015	CbGpPWpGaD
Fluocinonide—Hypertrichosis—Prednisone—psoriasis	7.76e-05	0.00186	CcSEcCtD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—CARM1—psoriasis	7.7e-05	0.0147	CbGpPWpGaD
Fluocinonide—Erythema—Tazarotene—psoriasis	7.66e-05	0.00184	CcSEcCtD
Fluocinonide—NR3C1—Circadian Clock—CARM1—psoriasis	7.48e-05	0.0143	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—psoriasis	7.44e-05	0.0142	CbGpPWpGaD
Fluocinonide—Pain—Calcipotriol—psoriasis	7.25e-05	0.00174	CcSEcCtD
Fluocinonide—Folliculitis—Cyclosporine—psoriasis	7.09e-05	0.0017	CcSEcCtD
Fluocinonide—Dry skin—Methoxsalen—psoriasis	7.03e-05	0.00169	CcSEcCtD
Fluocinonide—Leukoderma—Prednisone—psoriasis	6.94e-05	0.00167	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—CCL20—psoriasis	6.6e-05	0.0126	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HCAR2—psoriasis	6.52e-05	0.0125	CbGpPWpGaD
Fluocinonide—Erythema—Clobetasol propionate—psoriasis	6.49e-05	0.00156	CcSEcCtD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—psoriasis	6.48e-05	0.0124	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	6.45e-05	0.0123	CbGpPWpGaD
Fluocinonide—Eruption—Hydrocortisone—psoriasis	6.44e-05	0.00155	CcSEcCtD
Fluocinonide—Folliculitis—Hydrocortisone—psoriasis	6.3e-05	0.00151	CcSEcCtD
Fluocinonide—Skin exfoliation—Hydroxyurea—psoriasis	6.28e-05	0.00151	CcSEcCtD
Fluocinonide—Hypersensitivity—Calcipotriol—psoriasis	6.24e-05	0.0015	CcSEcCtD
Fluocinonide—Nasopharyngitis—Calcitriol—psoriasis	6.12e-05	0.00147	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptors—VDR—psoriasis	6e-05	0.0115	CbGpPWpGaD
Fluocinonide—Pruritus—Calcipotriol—psoriasis	6e-05	0.00144	CcSEcCtD
Fluocinonide—Folliculitis—Triamcinolone—psoriasis	5.94e-05	0.00143	CcSEcCtD
Fluocinonide—Leukoderma—Methotrexate—psoriasis	5.8e-05	0.00139	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	5.8e-05	0.0111	CbGpPWpGaD
Fluocinonide—Dry skin—Acitretin—psoriasis	5.58e-05	0.00134	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Clobetasol propionate—psoriasis	5.49e-05	0.00132	CcSEcCtD
Fluocinonide—Nasopharyngitis—Fluocinolone Acetonide—psoriasis	5.43e-05	0.0013	CcSEcCtD
Fluocinonide—Folliculitis—Betamethasone—psoriasis	5.39e-05	0.00129	CcSEcCtD
Fluocinonide—Folliculitis—Dexamethasone—psoriasis	5.39e-05	0.00129	CcSEcCtD
Fluocinonide—Rash—Calcipotriol—psoriasis	5.34e-05	0.00128	CcSEcCtD
Fluocinonide—Pain—Tazarotene—psoriasis	5.34e-05	0.00128	CcSEcCtD
Fluocinonide—Dermatitis—Calcipotriol—psoriasis	5.34e-05	0.00128	CcSEcCtD
Fluocinonide—Infection—Clobetasol propionate—psoriasis	5.26e-05	0.00126	CcSEcCtD
Fluocinonide—Skin disorder—Clobetasol propionate—psoriasis	5.15e-05	0.00124	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL13—psoriasis	5.04e-05	0.00965	CbGpPWpGaD
Fluocinonide—Glycosuria—Hydrocortisone—psoriasis	4.89e-05	0.00117	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	4.87e-05	0.00932	CbGpPWpGaD
Fluocinonide—Infection—Beclomethasone—psoriasis	4.79e-05	0.00115	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—VDR—psoriasis	4.74e-05	0.00908	CbGpPWpGaD
Fluocinonide—Erythema—Methoxsalen—psoriasis	4.62e-05	0.00111	CcSEcCtD
Fluocinonide—Glycosuria—Triamcinolone—psoriasis	4.61e-05	0.00111	CcSEcCtD
Fluocinonide—Swelling—Mycophenolic acid—psoriasis	4.53e-05	0.00109	CcSEcCtD
Fluocinonide—Pain—Clobetasol propionate—psoriasis	4.53e-05	0.00109	CcSEcCtD
Fluocinonide—Pruritus—Tazarotene—psoriasis	4.42e-05	0.00106	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptors—PPARG—psoriasis	4.18e-05	0.00801	CbGpPWpGaD
Fluocinonide—Glycosuria—Dexamethasone—psoriasis	4.18e-05	0.001	CcSEcCtD
Fluocinonide—Glycosuria—Betamethasone—psoriasis	4.18e-05	0.001	CcSEcCtD
Fluocinonide—Pain—Beclomethasone—psoriasis	4.12e-05	0.00099	CcSEcCtD
Fluocinonide—Erythema—Calcitriol—psoriasis	4.12e-05	0.000989	CcSEcCtD
Fluocinonide—Eruption—Methotrexate—psoriasis	4.01e-05	0.000962	CcSEcCtD
Fluocinonide—Rash—Tazarotene—psoriasis	3.94e-05	0.000946	CcSEcCtD
Fluocinonide—Dermatitis—Tazarotene—psoriasis	3.94e-05	0.000945	CcSEcCtD
Fluocinonide—Folliculitis—Methotrexate—psoriasis	3.92e-05	0.000941	CcSEcCtD
Fluocinonide—Dermatitis contact—Hydrocortisone—psoriasis	3.92e-05	0.000941	CcSEcCtD
Fluocinonide—Hypersensitivity—Clobetasol propionate—psoriasis	3.9e-05	0.000937	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—HCAR2—psoriasis	3.85e-05	0.00736	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—RUNX3—psoriasis	3.82e-05	0.00731	CbGpPWpGaD
Fluocinonide—Immune system disorder—Acitretin—psoriasis	3.8e-05	0.000913	CcSEcCtD
Fluocinonide—Skin exfoliation—Hydrocortisone—psoriasis	3.78e-05	0.000909	CcSEcCtD
Fluocinonide—Pruritus—Clobetasol propionate—psoriasis	3.75e-05	0.0009	CcSEcCtD
Fluocinonide—Infection—Methoxsalen—psoriasis	3.75e-05	0.0009	CcSEcCtD
Fluocinonide—Dermatitis contact—Triamcinolone—psoriasis	3.69e-05	0.000886	CcSEcCtD
Fluocinonide—Erythema—Acitretin—psoriasis	3.66e-05	0.00088	CcSEcCtD
Fluocinonide—Skin disorder—Methoxsalen—psoriasis	3.66e-05	0.00088	CcSEcCtD
Fluocinonide—Erythema—Fluocinolone Acetonide—psoriasis	3.65e-05	0.000878	CcSEcCtD
Fluocinonide—Glycosuria—Prednisone—psoriasis	3.64e-05	0.000874	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL10—psoriasis	3.58e-05	0.00685	CbGpPWpGaD
Fluocinonide—Nasopharyngitis—Mycophenolic acid—psoriasis	3.58e-05	0.000859	CcSEcCtD
Fluocinonide—Skin exfoliation—Triamcinolone—psoriasis	3.56e-05	0.000856	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL4—psoriasis	3.48e-05	0.00667	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—psoriasis	3.44e-05	0.00658	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCL20—psoriasis	3.38e-05	0.00648	CbGpPWpGaD
Fluocinonide—Dermatitis contact—Dexamethasone—psoriasis	3.35e-05	0.000804	CcSEcCtD
Fluocinonide—Dermatitis contact—Betamethasone—psoriasis	3.35e-05	0.000804	CcSEcCtD
Fluocinonide—Rash—Clobetasol propionate—psoriasis	3.34e-05	0.000802	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—TAGAP—psoriasis	3.34e-05	0.00639	CbGpPWpGaD
Fluocinonide—Dermatitis—Clobetasol propionate—psoriasis	3.34e-05	0.000801	CcSEcCtD
Fluocinonide—Headache—Clobetasol propionate—psoriasis	3.32e-05	0.000797	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—psoriasis	3.31e-05	0.00633	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	3.28e-05	0.00627	CbGpPWpGaD
Fluocinonide—Skin disorder—Calcitriol—psoriasis	3.26e-05	0.000784	CcSEcCtD
Fluocinonide—Skin exfoliation—Dexamethasone—psoriasis	3.23e-05	0.000776	CcSEcCtD
Fluocinonide—Skin exfoliation—Betamethasone—psoriasis	3.23e-05	0.000776	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	3.23e-05	0.00618	CbGpPWpGaD
Fluocinonide—Dizziness—Beclomethasone—psoriasis	3.19e-05	0.000766	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	3.19e-05	0.0061	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—HLA-A—psoriasis	3.16e-05	0.00604	CbGpPWpGaD
Fluocinonide—Hyperglycaemia—Mycophenolic acid—psoriasis	3.12e-05	0.000749	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.11e-05	0.00594	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL4—psoriasis	3.07e-05	0.00587	CbGpPWpGaD
Fluocinonide—Rash—Beclomethasone—psoriasis	3.04e-05	0.00073	CcSEcCtD
Fluocinonide—Dermatitis—Beclomethasone—psoriasis	3.04e-05	0.00073	CcSEcCtD
Fluocinonide—Headache—Beclomethasone—psoriasis	3.02e-05	0.000726	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL13—psoriasis	3.02e-05	0.00577	CbGpPWpGaD
Fluocinonide—Infection—Acitretin—psoriasis	2.97e-05	0.000714	CcSEcCtD
Fluocinonide—Dry skin—Cyclosporine—psoriasis	2.97e-05	0.000713	CcSEcCtD
Fluocinonide—Infection—Fluocinolone Acetonide—psoriasis	2.96e-05	0.000712	CcSEcCtD
Fluocinonide—Nervous system disorder—Fluocinolone Acetonide—psoriasis	2.92e-05	0.000702	CcSEcCtD
Fluocinonide—Skin disorder—Acitretin—psoriasis	2.9e-05	0.000698	CcSEcCtD
Fluocinonide—Erythema—Hydroxyurea—psoriasis	2.88e-05	0.000691	CcSEcCtD
Fluocinonide—Pain—Calcitriol—psoriasis	2.87e-05	0.00069	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.82e-05	0.0054	CbGpPWpGaD
Fluocinonide—Skin exfoliation—Prednisone—psoriasis	2.81e-05	0.000676	CcSEcCtD
Fluocinonide—Hypersensitivity—Methoxsalen—psoriasis	2.78e-05	0.000667	CcSEcCtD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—psoriasis	2.78e-05	0.00531	CbGpPWpGaD
Fluocinonide—Dry skin—Prednisolone—psoriasis	2.7e-05	0.000648	CcSEcCtD
Fluocinonide—Pruritus—Methoxsalen—psoriasis	2.67e-05	0.000641	CcSEcCtD
Fluocinonide—Dry skin—Hydrocortisone—psoriasis	2.64e-05	0.000633	CcSEcCtD
Fluocinonide—Pain—Acitretin—psoriasis	2.56e-05	0.000614	CcSEcCtD
Fluocinonide—Pain—Fluocinolone Acetonide—psoriasis	2.55e-05	0.000612	CcSEcCtD
Fluocinonide—Hyperglycaemia—Cyclosporine—psoriasis	2.52e-05	0.000606	CcSEcCtD
Fluocinonide—Dizziness—Methoxsalen—psoriasis	2.49e-05	0.000599	CcSEcCtD
Fluocinonide—Hypersensitivity—Calcitriol—psoriasis	2.48e-05	0.000595	CcSEcCtD
Fluocinonide—Hyperglycaemia—Mycophenolate mofetil—psoriasis	2.46e-05	0.000591	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—psoriasis	2.44e-05	0.00467	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—SOCS1—psoriasis	2.43e-05	0.00466	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—psoriasis	2.43e-05	0.000584	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.42e-05	0.00462	CbGpPWpGaD
Fluocinonide—Pruritus—Calcitriol—psoriasis	2.38e-05	0.000571	CcSEcCtD
Fluocinonide—Rash—Methoxsalen—psoriasis	2.38e-05	0.000571	CcSEcCtD
Fluocinonide—Dermatitis—Methoxsalen—psoriasis	2.38e-05	0.000571	CcSEcCtD
Fluocinonide—Headache—Methoxsalen—psoriasis	2.36e-05	0.000567	CcSEcCtD
Fluocinonide—Skin exfoliation—Methotrexate—psoriasis	2.35e-05	0.000565	CcSEcCtD
Fluocinonide—Infection—Hydroxyurea—psoriasis	2.33e-05	0.00056	CcSEcCtD
Fluocinonide—Nervous system disorder—Hydroxyurea—psoriasis	2.3e-05	0.000553	CcSEcCtD
Fluocinonide—Skin disorder—Hydroxyurea—psoriasis	2.28e-05	0.000548	CcSEcCtD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—JUN—psoriasis	2.27e-05	0.00435	CbGpPWpGaD
Fluocinonide—Dry skin—Betamethasone—psoriasis	2.25e-05	0.000541	CcSEcCtD
Fluocinonide—Dry skin—Dexamethasone—psoriasis	2.25e-05	0.000541	CcSEcCtD
Fluocinonide—Hypersensitivity—Acitretin—psoriasis	2.2e-05	0.000529	CcSEcCtD
Fluocinonide—Hypersensitivity—Fluocinolone Acetonide—psoriasis	2.2e-05	0.000528	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.13e-05	0.00408	CbGpPWpGaD
Fluocinonide—Rash—Calcitriol—psoriasis	2.12e-05	0.000509	CcSEcCtD
Fluocinonide—Dermatitis—Calcitriol—psoriasis	2.12e-05	0.000509	CcSEcCtD
Fluocinonide—Pruritus—Acitretin—psoriasis	2.12e-05	0.000508	CcSEcCtD
Fluocinonide—Pruritus—Fluocinolone Acetonide—psoriasis	2.11e-05	0.000507	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—IFNG—psoriasis	2.11e-05	0.00403	CbGpPWpGaD
Fluocinonide—Headache—Calcitriol—psoriasis	2.11e-05	0.000506	CcSEcCtD
Fluocinonide—NR3C1—Gene Expression—TARS—psoriasis	2.1e-05	0.00402	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	2.04e-05	0.000489	CcSEcCtD
Fluocinonide—Pain—Hydroxyurea—psoriasis	2.01e-05	0.000482	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—CCL20—psoriasis	2e-05	0.00383	CbGpPWpGaD
Fluocinonide—Dizziness—Acitretin—psoriasis	1.98e-05	0.000475	CcSEcCtD
Fluocinonide—Dizziness—Fluocinolone Acetonide—psoriasis	1.97e-05	0.000474	CcSEcCtD
Fluocinonide—Dry skin—Prednisone—psoriasis	1.96e-05	0.000471	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—CXCL8—psoriasis	1.96e-05	0.00375	CbGpPWpGaD
Fluocinonide—Infection—Mycophenolic acid—psoriasis	1.95e-05	0.000469	CcSEcCtD
Fluocinonide—Nervous system disorder—Mycophenolic acid—psoriasis	1.93e-05	0.000463	CcSEcCtD
Fluocinonide—Hyperglycaemia—Betamethasone—psoriasis	1.92e-05	0.00046	CcSEcCtD
Fluocinonide—Hyperglycaemia—Dexamethasone—psoriasis	1.92e-05	0.00046	CcSEcCtD
Fluocinonide—Skin disorder—Mycophenolic acid—psoriasis	1.91e-05	0.000459	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL10—psoriasis	1.89e-05	0.00361	CbGpPWpGaD
Fluocinonide—Rash—Acitretin—psoriasis	1.89e-05	0.000453	CcSEcCtD
Fluocinonide—Dermatitis—Acitretin—psoriasis	1.88e-05	0.000452	CcSEcCtD
Fluocinonide—Rash—Fluocinolone Acetonide—psoriasis	1.88e-05	0.000452	CcSEcCtD
Fluocinonide—Dermatitis—Fluocinolone Acetonide—psoriasis	1.88e-05	0.000451	CcSEcCtD
Fluocinonide—Headache—Acitretin—psoriasis	1.87e-05	0.00045	CcSEcCtD
Fluocinonide—Headache—Fluocinolone Acetonide—psoriasis	1.87e-05	0.000449	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—psoriasis	1.86e-05	0.00355	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—JUN—psoriasis	1.82e-05	0.00348	CbGpPWpGaD
Fluocinonide—Immune system disorder—Hydrocortisone—psoriasis	1.8e-05	0.000432	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—LEP—psoriasis	1.8e-05	0.00344	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CXCL8—psoriasis	1.78e-05	0.00341	CbGpPWpGaD
Fluocinonide—Erythema—Prednisolone—psoriasis	1.77e-05	0.000426	CcSEcCtD
Fluocinonide—Erythema—Hydrocortisone—psoriasis	1.73e-05	0.000416	CcSEcCtD
Fluocinonide—Hypersensitivity—Hydroxyurea—psoriasis	1.73e-05	0.000415	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—psoriasis	1.73e-05	0.0033	CbGpPWpGaD
Fluocinonide—Pain—Mycophenolic acid—psoriasis	1.68e-05	0.000404	CcSEcCtD
Fluocinonide—Hyperglycaemia—Prednisone—psoriasis	1.67e-05	0.000401	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	1.65e-05	0.000396	CcSEcCtD
Fluocinonide—Erythema—Triamcinolone—psoriasis	1.63e-05	0.000392	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	1.62e-05	0.0031	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	1.61e-05	0.000386	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—psoriasis	1.6e-05	0.00307	CbGpPWpGaD
Fluocinonide—Infection—Cyclosporine—psoriasis	1.58e-05	0.00038	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—PPARG—psoriasis	1.56e-05	0.00299	CbGpPWpGaD
Fluocinonide—Nervous system disorder—Cyclosporine—psoriasis	1.56e-05	0.000375	CcSEcCtD
Fluocinonide—Dizziness—Hydroxyurea—psoriasis	1.55e-05	0.000373	CcSEcCtD
Fluocinonide—Skin disorder—Cyclosporine—psoriasis	1.55e-05	0.000371	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	1.54e-05	0.00295	CbGpPWpGaD
Fluocinonide—Infection—Mycophenolate mofetil—psoriasis	1.54e-05	0.00037	CcSEcCtD
Fluocinonide—Nervous system disorder—Mycophenolate mofetil—psoriasis	1.52e-05	0.000365	CcSEcCtD
Fluocinonide—Skin disorder—Mycophenolate mofetil—psoriasis	1.51e-05	0.000362	CcSEcCtD
Fluocinonide—Rash—Hydroxyurea—psoriasis	1.48e-05	0.000356	CcSEcCtD
Fluocinonide—Erythema—Dexamethasone—psoriasis	1.48e-05	0.000355	CcSEcCtD
Fluocinonide—Erythema—Betamethasone—psoriasis	1.48e-05	0.000355	CcSEcCtD
Fluocinonide—Dermatitis—Hydroxyurea—psoriasis	1.48e-05	0.000355	CcSEcCtD
Fluocinonide—Headache—Hydroxyurea—psoriasis	1.47e-05	0.000353	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	1.46e-05	0.000352	CcSEcCtD
Fluocinonide—Infection—Hydrocortisone—psoriasis	1.4e-05	0.000337	CcSEcCtD
Fluocinonide—Pruritus—Mycophenolic acid—psoriasis	1.39e-05	0.000334	CcSEcCtD
Fluocinonide—Nervous system disorder—Hydrocortisone—psoriasis	1.39e-05	0.000333	CcSEcCtD
Fluocinonide—Skin disorder—Hydrocortisone—psoriasis	1.37e-05	0.00033	CcSEcCtD
Fluocinonide—NR3C1—Generic Transcription Pathway—CARM1—psoriasis	1.37e-05	0.00263	CbGpPWpGaD
Fluocinonide—Pain—Cyclosporine—psoriasis	1.36e-05	0.000327	CcSEcCtD
Fluocinonide—Immune system disorder—Prednisone—psoriasis	1.34e-05	0.000321	CcSEcCtD
Fluocinonide—Pain—Mycophenolate mofetil—psoriasis	1.33e-05	0.000319	CcSEcCtD
Fluocinonide—Infection—Triamcinolone—psoriasis	1.32e-05	0.000318	CcSEcCtD
Fluocinonide—Dizziness—Mycophenolic acid—psoriasis	1.3e-05	0.000312	CcSEcCtD
Fluocinonide—Erythema—Prednisone—psoriasis	1.29e-05	0.00031	CcSEcCtD
Fluocinonide—Rash—Mycophenolic acid—psoriasis	1.24e-05	0.000298	CcSEcCtD
Fluocinonide—Dermatitis—Mycophenolic acid—psoriasis	1.24e-05	0.000297	CcSEcCtD
Fluocinonide—Pain—Prednisolone—psoriasis	1.24e-05	0.000297	CcSEcCtD
Fluocinonide—Headache—Mycophenolic acid—psoriasis	1.23e-05	0.000296	CcSEcCtD
Fluocinonide—Pain—Hydrocortisone—psoriasis	1.21e-05	0.00029	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—TP53—psoriasis	1.2e-05	0.0023	CbGpPWpGaD
Fluocinonide—Infection—Betamethasone—psoriasis	1.2e-05	0.000288	CcSEcCtD
Fluocinonide—Infection—Dexamethasone—psoriasis	1.2e-05	0.000288	CcSEcCtD
Fluocinonide—Nervous system disorder—Dexamethasone—psoriasis	1.18e-05	0.000284	CcSEcCtD
Fluocinonide—Nervous system disorder—Betamethasone—psoriasis	1.18e-05	0.000284	CcSEcCtD
Fluocinonide—Hypersensitivity—Cyclosporine—psoriasis	1.17e-05	0.000281	CcSEcCtD
Fluocinonide—Hypersensitivity—Mycophenolate mofetil—psoriasis	1.14e-05	0.000275	CcSEcCtD
Fluocinonide—Pain—Triamcinolone—psoriasis	1.14e-05	0.000273	CcSEcCtD
Fluocinonide—Pruritus—Cyclosporine—psoriasis	1.13e-05	0.00027	CcSEcCtD
Fluocinonide—Immune system disorder—Methotrexate—psoriasis	1.12e-05	0.000268	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—SOCS1—psoriasis	1.1e-05	0.00211	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL6—psoriasis	1.1e-05	0.0021	CbGpPWpGaD
Fluocinonide—Pruritus—Mycophenolate mofetil—psoriasis	1.1e-05	0.000264	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	1.09e-05	0.000262	CcSEcCtD
Fluocinonide—Erythema—Methotrexate—psoriasis	1.08e-05	0.000259	CcSEcCtD
Fluocinonide—Hypersensitivity—Prednisolone—psoriasis	1.07e-05	0.000256	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—psoriasis	1.06e-05	0.00203	CbGpPWpGaD
Fluocinonide—Dizziness—Cyclosporine—psoriasis	1.05e-05	0.000253	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—TYK2—psoriasis	1.05e-05	0.00201	CbGpPWpGaD
Fluocinonide—Infection—Prednisone—psoriasis	1.04e-05	0.000251	CcSEcCtD
Fluocinonide—Hypersensitivity—Hydrocortisone—psoriasis	1.04e-05	0.00025	CcSEcCtD
Fluocinonide—Pain—Dexamethasone—psoriasis	1.03e-05	0.000248	CcSEcCtD
Fluocinonide—Pain—Betamethasone—psoriasis	1.03e-05	0.000248	CcSEcCtD
Fluocinonide—Nervous system disorder—Prednisone—psoriasis	1.03e-05	0.000248	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—psoriasis	1.03e-05	0.00197	CbGpPWpGaD
Fluocinonide—Dizziness—Mycophenolate mofetil—psoriasis	1.03e-05	0.000246	CcSEcCtD
Fluocinonide—Skin disorder—Prednisone—psoriasis	1.02e-05	0.000245	CcSEcCtD
Fluocinonide—Rash—Cyclosporine—psoriasis	1e-05	0.000241	CcSEcCtD
Fluocinonide—Dermatitis—Cyclosporine—psoriasis	1e-05	0.000241	CcSEcCtD
Fluocinonide—Pruritus—Hydrocortisone—psoriasis	1e-05	0.00024	CcSEcCtD
Fluocinonide—Headache—Cyclosporine—psoriasis	9.97e-06	0.000239	CcSEcCtD
Fluocinonide—Hypersensitivity—Triamcinolone—psoriasis	9.81e-06	0.000236	CcSEcCtD
Fluocinonide—Rash—Mycophenolate mofetil—psoriasis	9.78e-06	0.000235	CcSEcCtD
Fluocinonide—Dermatitis—Mycophenolate mofetil—psoriasis	9.78e-06	0.000235	CcSEcCtD
Fluocinonide—Headache—Mycophenolate mofetil—psoriasis	9.72e-06	0.000233	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—psoriasis	9.69e-06	0.00185	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—STAT3—psoriasis	9.6e-06	0.00184	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—JUN—psoriasis	9.59e-06	0.00183	CbGpPWpGaD
Fluocinonide—Dizziness—Prednisolone—psoriasis	9.57e-06	0.00023	CcSEcCtD
Fluocinonide—Pruritus—Triamcinolone—psoriasis	9.42e-06	0.000226	CcSEcCtD
Fluocinonide—Dizziness—Hydrocortisone—psoriasis	9.35e-06	0.000225	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—psoriasis	9.23e-06	0.00177	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CXCL8—psoriasis	9.14e-06	0.00175	CbGpPWpGaD
Fluocinonide—Rash—Prednisolone—psoriasis	9.13e-06	0.000219	CcSEcCtD
Fluocinonide—Dermatitis—Prednisolone—psoriasis	9.12e-06	0.000219	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	9.11e-06	0.000219	CcSEcCtD
Fluocinonide—Headache—Prednisolone—psoriasis	9.07e-06	0.000218	CcSEcCtD
Fluocinonide—Rash—Hydrocortisone—psoriasis	8.91e-06	0.000214	CcSEcCtD
Fluocinonide—Dermatitis—Hydrocortisone—psoriasis	8.91e-06	0.000214	CcSEcCtD
Fluocinonide—Headache—Hydrocortisone—psoriasis	8.86e-06	0.000213	CcSEcCtD
Fluocinonide—Dizziness—Triamcinolone—psoriasis	8.8e-06	0.000211	CcSEcCtD
Fluocinonide—Infection—Methotrexate—psoriasis	8.73e-06	0.00021	CcSEcCtD
Fluocinonide—Nervous system disorder—Methotrexate—psoriasis	8.62e-06	0.000207	CcSEcCtD
Fluocinonide—Pruritus—Betamethasone—psoriasis	8.55e-06	0.000205	CcSEcCtD
Fluocinonide—Pruritus—Dexamethasone—psoriasis	8.55e-06	0.000205	CcSEcCtD
Fluocinonide—Skin disorder—Methotrexate—psoriasis	8.54e-06	0.000205	CcSEcCtD
Fluocinonide—Rash—Triamcinolone—psoriasis	8.39e-06	0.000202	CcSEcCtD
Fluocinonide—Dermatitis—Triamcinolone—psoriasis	8.39e-06	0.000201	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—psoriasis	8.38e-06	0.0016	CbGpPWpGaD
Fluocinonide—Headache—Triamcinolone—psoriasis	8.34e-06	0.0002	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—TNF—psoriasis	8.31e-06	0.00159	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—VDR—psoriasis	8.19e-06	0.00157	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOE—psoriasis	8.13e-06	0.00155	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LEP—psoriasis	8.13e-06	0.00155	CbGpPWpGaD
Fluocinonide—Dizziness—Betamethasone—psoriasis	7.99e-06	0.000192	CcSEcCtD
Fluocinonide—Dizziness—Dexamethasone—psoriasis	7.99e-06	0.000192	CcSEcCtD
Fluocinonide—Hypersensitivity—Prednisone—psoriasis	7.75e-06	0.000186	CcSEcCtD
Fluocinonide—Rash—Dexamethasone—psoriasis	7.62e-06	0.000183	CcSEcCtD
Fluocinonide—Rash—Betamethasone—psoriasis	7.62e-06	0.000183	CcSEcCtD
Fluocinonide—Dermatitis—Dexamethasone—psoriasis	7.61e-06	0.000183	CcSEcCtD
Fluocinonide—Dermatitis—Betamethasone—psoriasis	7.61e-06	0.000183	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—NFKBIA—psoriasis	7.57e-06	0.00145	CbGpPWpGaD
Fluocinonide—Headache—Dexamethasone—psoriasis	7.57e-06	0.000182	CcSEcCtD
Fluocinonide—Headache—Betamethasone—psoriasis	7.57e-06	0.000182	CcSEcCtD
Fluocinonide—Pain—Methotrexate—psoriasis	7.52e-06	0.000181	CcSEcCtD
Fluocinonide—Pruritus—Prednisone—psoriasis	7.44e-06	0.000179	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TNF—psoriasis	7.18e-06	0.00137	CbGpPWpGaD
Fluocinonide—Dizziness—Prednisone—psoriasis	6.96e-06	0.000167	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—IL6—psoriasis	6.7e-06	0.00128	CbGpPWpGaD
Fluocinonide—Rash—Prednisone—psoriasis	6.63e-06	0.000159	CcSEcCtD
Fluocinonide—Dermatitis—Prednisone—psoriasis	6.63e-06	0.000159	CcSEcCtD
Fluocinonide—NR3C1—Gene Expression—CARM1—psoriasis	6.61e-06	0.00126	CbGpPWpGaD
Fluocinonide—Headache—Prednisone—psoriasis	6.59e-06	0.000158	CcSEcCtD
Fluocinonide—Hypersensitivity—Methotrexate—psoriasis	6.48e-06	0.000156	CcSEcCtD
Fluocinonide—Pruritus—Methotrexate—psoriasis	6.22e-06	0.000149	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—TYK2—psoriasis	6.2e-06	0.00119	CbGpPWpGaD
Fluocinonide—Dizziness—Methotrexate—psoriasis	5.81e-06	0.00014	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL6—psoriasis	5.79e-06	0.00111	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PPARG—psoriasis	5.71e-06	0.00109	CbGpPWpGaD
Fluocinonide—Rash—Methotrexate—psoriasis	5.54e-06	0.000133	CcSEcCtD
Fluocinonide—Dermatitis—Methotrexate—psoriasis	5.54e-06	0.000133	CcSEcCtD
Fluocinonide—Headache—Methotrexate—psoriasis	5.51e-06	0.000132	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—CXCL8—psoriasis	5.4e-06	0.00103	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL6—psoriasis	5.13e-06	0.000982	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—JUN—psoriasis	5.02e-06	0.00096	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NFKB1—psoriasis	4.83e-06	0.000924	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VEGFA—psoriasis	4.39e-06	0.000839	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—STAT3—psoriasis	4.34e-06	0.000831	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—VDR—psoriasis	3.94e-06	0.000755	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TP53—psoriasis	3.31e-06	0.000634	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL6—psoriasis	3.03e-06	0.00058	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PPARG—psoriasis	2.75e-06	0.000526	CbGpPWpGaD
